Iconlab, Inc. v. Bausch Health Companies, Inc.

CourtCourt of Appeals for the Ninth Circuit
DecidedSeptember 22, 2020
Docket19-55683
StatusUnpublished

This text of Iconlab, Inc. v. Bausch Health Companies, Inc. (Iconlab, Inc. v. Bausch Health Companies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Iconlab, Inc. v. Bausch Health Companies, Inc., (9th Cir. 2020).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS SEP 22 2020 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

ICONLAB, INC., a California corporation; No. 19-55683 et al., D.C. No. Plaintiffs-Appellants, 8:16-cv-01321-JLS-KES

v. MEMORANDUM* BAUSCH HEALTH COMPANIES, INC., FKA Valeant Pharmaceuticals International, Inc., a Canadian corporation; et al.,

Defendants-Appellees.

Appeal from the United States District Court for the Central District of California Josephine L. Staton, District Judge, Presiding

Submitted August 14, 2020** Pasadena, California

Before: CALLAHAN, BUMATAY, and VANDYKE, Circuit Judges.

Iconlab, Inc., Icon Lab GmbH, and Reper-NN, Co., Ltd. (collectively,

“Iconlab”) appeal from the grant of Bausch Health Companies, Inc.’s motions to

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). dismiss for lack of personal jurisdiction and for failure to join indispensable parties.

We affirm.

1. We review personal jurisdiction determinations de novo, Dole Food Co. v.

Watts, 303 F.3d 1104, 1108 (9th Cir. 2002), and factual questions involved in the

application of alter ego and agency tests for clear error. Towe Antique Ford Found.

v. I.R.S., 999 F.2d 1387, 1391 (9th Cir. 1993); Penthouse Int’l, Ltd. v. Barnes, 792

F.2d 943, 947 (9th Cir. 1986). We apply state law to questions of jurisdiction.

Williams v. Yamaha Motor Co., 851 F.3d 1015, 1020 (9th Cir. 2017). In this case,

the district court, after months of jurisdictional discovery, granted Bausch’s Federal

Rule of Civil Procedure 12(b)(2) motion to dismiss Bausch’s foreign subsidiaries,

Valeant Ireland and B&L Saglik, for lack of jurisdiction over both Iconlab’s alter

ego and agency theories. The district court did not err.

To support personal jurisdiction under an alter ego theory, Iconlab must show

(1) “such unity of interest and ownership” between parent and subsidiary “that the

separate personalities of the two entities no longer exist” and (2) the “failure to

disregard” the separate entities “would result in fraud or injustice.” Ranza v. Nike,

Inc., 793 F.3d 1059, 1073 (9th Cir. 2015) (simplified) (quoting Doe v. Unocal Corp.,

248 F.3d 915, 926 (9th Cir. 2001)). Iconlab argues there is sufficient unity of interest

between Bausch and its two foreign subsidiaries because Bausch approved their

large purchases, financed their activity, issued collective media releases, and

2 submitted consolidated earnings reports. The district court was correct that none of

these allegations show Bausch’s day-to-day involvement in its subsidiaries’

governance. See Ranza, 793 F.3d at 1073 (recognizing that the “test envisions

pervasive control over the subsidiary, . . . from broad policy decision to routine

matters of day-to-day operation”) (simplified). Instead, these activities reflect

routine operations between a parent and its subsidiary.1 Furthermore, Iconlab fails

the second part of the test: it has not shown that injustice would result here from

“recognition of the corporate form.” Tomaselli v. Transamerica Ins. Co., 31 Cal.

Rptr. 2d 433, 443 (Ct. App. 1994) (finding “inadequate capitalization, commingling

of assets, [and] disregard of corporate formalities” can satisfy the standard).

The district court also correctly rejected Iconlab’s effort to support

jurisdiction under an agency theory. Iconlab asserted that the two foreign

subsidiaries are Bausch’s agents, but it relies on a theory of agency, Bowoto v.

Chevron Texaco Corp., 312 F. Supp. 2d 1229, 1238–46 (N.D. Cal. 2004), that was

rejected by the Court in Daimler AG v. Bauman, 571 U.S. 117, 136 (2014). See also

Yamaha Motor, 851 F.3d at 1021 (recognizing that the test for general jurisdiction

1 See, e.g., Unocal Corp., 248 F.3d at 927, abrogated on other grounds by Williams v. Yamaha Motor Co., 851 F.3d 1015 (9th Cir. 2017) (financing and approval of large purchases); Sonora Diamond Corp. v. Superior Court, 99 Cal. Rptr. 2d 824, 844 (Ct. App. 2000) (consolidated reporting); Kramer Motors, Inc. v. British Leyland, Ltd., 628 F.2d 1175, 1177 (9th Cir. 1980) (guarantor); F. Hoffman-La Roche, Ltd. v. Superior Court, 30 Cal. Rptr. 3d 407, 422 (Ct. App. 2005) (collective media releases).

3 asks whether a corporation is essentially “at home” in the forum state). Even

assuming Iconlab’s agency theory is still actionable, Iconlab employs a novel

“reverse-agency” theory with no legal support: attributing to the agents (foreign

subsidiaries) the contacts of the principal (Bausch). See Strasner v. Touchstone

Wireless Repair & Logistics, LP, 210 Cal. Rptr. 3d 16, 24 (Ct. App. 2016) (rejecting

jurisdictional imputation through reverse agency). We decline to approve this theory

here.

2. Next, the district court did not abuse its discretion by dismissing Iconlab’s

lawsuit under Federal Rule of Civil Procedure 19. The Rule 19 inquiry involves: (1)

identifying the necessary absent parties; (2) determining if joinder is feasible;2 and

(3) choosing whether to proceed without them. See Fed R. Civ. P. 19(a)–(b);

E.E.O.C. v. Peabody W. Coal Co., 400 F.3d 774, 779–80 (9th Cir. 2005). The absent

parties consisted of Bausch’s foreign subsidiaries Valeant Ireland, B&L Saglik, and

Valeant International Luxembourg (collectively, “Valeant subsidiaries”), Turkish

company Boyut, and UAE-incorporated Mediworld.

Under Rule 19(a)(1)(B), a party must be joined if:

That person claims an interest relating to the subject of the action and is so situated that disposing of the action in the person’s absence may: (i) as a practical matter impair or impede the person’s ability to protect the interest; or (ii) leave an existing party subject to a substantial risk

2 Iconlab does not challenge this prong of the Rule 19 inquiry and we do not address it here.

4 of incurring double, multiple, or otherwise inconsistent obligations because of the interest.

Fed R. Civ. P. 19(a)(1)(B). Here, the district court ruled that the absent parties were

necessary to determine the ownership of the technology at the heart of the dispute

between Iconlab and Bausch. According to Bausch, the Valeant subsidiaries were

the purported buyers of the commercial technology and Boyut and Mediworld were

the purported sellers. But Iconlab sought damages, declaratory relief naming it the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kramer Motors, Inc. v. British Leyland, Ltd.
628 F.2d 1175 (Ninth Circuit, 1980)
F. HOFFMAN-LA ROCHE, LTD. v. Superior Court
30 Cal. Rptr. 3d 407 (California Court of Appeal, 2005)
Sonora Diamond Corp. v. Superior Court
99 Cal. Rptr. 2d 824 (California Court of Appeal, 2000)
Tomaselli v. Transamerica Insurance
25 Cal. App. 4th 1269 (California Court of Appeal, 1994)
Bowoto v. Chevron Texaco Corp.
312 F. Supp. 2d 1229 (N.D. California, 2004)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Loredana Ranza v. Nike, Inc.
793 F.3d 1059 (Ninth Circuit, 2015)
Strasner v. Touchstone Wireless Repair & Logistics, LP
5 Cal. App. 5th 215 (California Court of Appeal, 2016)
George Williams v. Yamaha Motor Corp. USA
851 F.3d 1015 (Ninth Circuit, 2017)
Doe v. Unocal Corp.
248 F.3d 915 (Ninth Circuit, 2001)
Dole Food Co. v. Watts
303 F.3d 1104 (Ninth Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Iconlab, Inc. v. Bausch Health Companies, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/iconlab-inc-v-bausch-health-companies-inc-ca9-2020.